The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003
Slater Revisited:6 Year Follow Up Study of Pts with Medically Unexplained Motor Symptoms
BMJ 316:582-586, 5641998., Crimlisk,H.L.,et al, 1998
Outcome in Conversion Disorder:A Follow Up Study
JNNP 58:750-752, Couprie,W.,et al, 1995
Somatisation in Neurlogic Practice
JNNP 57:1161-1164, Ron,M.A., 1994
Hysterical Hemiparesis Accompanying Bell's Palsy
Neurol 43:1619, Keane,J.R., 1993
Brief Communication: Psychogenic Sensory Loss
J Nerv Ment Dis 176:686-687, Rolak,L.A., 1988
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
American Academy of Neurology Telehealth Position Statement
Neurol 97:334-339, Hatcher-Martin, J.M.,et al, 2021
Neurologic Features in Severe SARS-CoV-2 Infection
NEJM 382:2268-2270, e110, , 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection
JAMA Neurol 77:679-680, Pleasure, S.J.,et al, 2020
Training in Neurology: Flexibility and Adaptability of a Neurology Training Program at the Epicenter of COVID-19
Neurol 94:e2608-e2614, Agarwal, S.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Clinicopathologic Conference, Cerebrovascular Accident Probably Related to SARS-CoV2 Infection
NEJM 383:764-773, Case 26-2020, 2020
Complications from "Stem Cell Tourism" in Neurology
Ann Neurol 88:661-668, Julian, K.,et al, 2020
Testing the Reflexes
BMJ 366:l4830, Lees, A.J. & Hurwitz, B., 2019
Medical Use of Cannabis in 2019
JAMA 322:974-975, Hill, K.P., 2019
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018
Zika Virus as a Cause of Neurologic Disorders
NEJM 374:1506-1509, Broutet, N.,et al, 2016
Clinicopathologic Conference, Aqueductal Stenosis with Hydrocephalus
NEJM 375:2583-2593, Case 40-2016, 2016
The Importance of Lesbian, Gay, Bisexual and Transgender Health in Neurology
JAMA Neurol 72:855, Rosendale, N. & Josephson, S.A., 2015
The Safety of Aeroplane Travel in Patients with Symptomatic Carotid Occlusion
JNNP 85:435-437, Reynolds, M.R.,et al, 2014
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Autism and Mental Retardation among Offspring born after In Vitro Fertilization
JAMA 310:75-84, Sandin, S.,et al, 2013
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Neurological Injury in Adults Treated with Extracorporeal Membrane Oxygenation
Arch Neurol 68:1543-1549, Mateen, F.J.,et al, 2011
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Deep Brain Stimulation
Neurologist 13:237-252, Kem,DS. &Kumar,R., 2007
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Oral Antispastic Drugs in Nonprogressive Neurologic Diseases
Neurol 63:1357-1363, Montane,E.,et al, 2004
Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003
Intravenous Immunoglobulin in Neurological Disease: A specialist Review
JNNP 72:440-448, Wiles,C.M.,et al, 2002
Presence of Chlamydia pneumoniae DNA in the Cerebral Spinal Fluid is a Common Phenomenon in a Variety of Neurological Diseases and Not Restricted to Multiple Sclerosis
Ann Neurol 49:585-589,556, Gieffers,J.,et al, 2001
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Neurologic Consequences of HTLV-II Infection in Injection-Drug Users
Neurol 46:1556-1560, Dooneief,G.,et al, 1996
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Isolation of HTLV-II from Pt with Chronic, Prog Neurol Dis Clin Indistinguish from HAM/Tropical Spastic Paraparesis
Ann Neurol 33:392-396, Jacobson,S.,et al, 1993
Molecular Genetics in Neurology
Ann Neurol 34:757-773, Martin,J.B., 1993
Irregular Breathing
In Internal Medicine, Little, Brown & Co, Boston, 3rd Ed, p. 573-574, Cherniack,N.S., 1990